首頁 > 市場調查報告書 > 醫療設備

e保健行動醫療

智慧糖尿病管理市場規模、佔有率及成長分析（按設備、應用、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1902524

智慧糖尿病管理市場規模、佔有率及成長分析（按設備、應用、最終用戶和地區分類）－2026-2033年產業預測

Smart Diabetes Management Market Size, Share, and Growth Analysis, By Device Type (Handheld, Wearable), By Application (Type 1 Diabetes, Type 2 Diabetes), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球智慧糖尿病管理市場規模預計在 2024 年達到 69.3 億美元，從 2025 年的 79.5 億美元成長到 2033 年的 238.1 億美元，在預測期（2026-2033 年）內複合年成長率為 14.7%。

受醫療技術進步和對個人化解決方案日益成長的需求推動，全球智慧糖尿病管理市場正經歷顯著擴張。關鍵成長要素包括人們對糖尿病護理意識的提高、全球糖尿病患者數量的成長以及對能夠簡化監測和治療流程的創新設備的需求。製造商和醫療保健提供者正積極開發智慧型裝置、穿戴式裝置和行動應用程式，以提高糖尿病患者的生活品質，最終改善疾病管理並最大限度地減少併發症。將人工智慧 (AI) 和數據分析融入這些解決方案，為更個人化的糖尿病照護提供了廣闊的前景。隨著健康和福祉持續成為全球關注的焦點，預計該市場將保持持續成長，為不斷擴大的糖尿病患者群體提供尖端解決方案。

全球智慧糖尿病管理市場促進因素

全球智慧糖尿病管理市場的主要促進因素之一是全球糖尿病盛行率的不斷上升，以及肥胖率的上升和久坐生活方式的盛行。隨著糖尿病的日益普遍，創新管理解決方案的需求也隨之成長。穿戴式裝置、行動應用程式和持續血糖監測系統等智慧糖尿病管理技術能夠為患者提供即時數據和健康狀況分析。這種向個人化和主動式健康管理的轉變不僅提高了患者的參與度，還有助於改善整體治療效果，從而進一步推動市場擴張，並吸引對糖尿病護理相關新技術和解決方案的投資。

限制全球智慧糖尿病管理市場的因素

全球智慧糖尿病管理市場的主要限制因素之一是先進監測設備和數位化醫療解決方案的高成本。許多醣尿病患者，尤其是在醫療預算有限的中低收入地區，都感受到採用這些創新技術所帶來的經濟負擔。此外，缺乏智慧糖尿病管理工具的報銷政策也阻礙了醫療專業人員和患者的使用。再者，患者技術素養水平的差異也影響了這些設備的有效使用，進一步阻礙了市場成長，限制了智慧糖尿病管理解決方案的廣泛應用。

全球智慧糖尿病管理市場趨勢

全球智慧糖尿病管理市場正經歷強勁成長，主要驅動力是全球糖尿病盛行率的不斷攀升。隨著人口老化和久坐生活方式的日益普遍，糖尿病發病率持續上升，導致患者群體不斷擴大，對先進管理解決方案的需求也日益成長。這種人口結構的變化推動了對創新技術的需求，這些技術能夠改善糖尿病監測、個人化護理和即時數據分析。隨著醫療保健系統將有效的管理策略置於優先地位，對智慧型裝置、行動應用程式和遠端醫療服務的投資激增，為滿足患者和醫療保健提供者不斷變化的需求的綜合糖尿病管理解決方案創造了充滿活力的環境。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Abbott Laboratories（United States）
Dexcom, Inc.（United States）
Medtronic plc（Ireland）
Insulet Corporation（United States）
F. Hoffmann-La Roche Ltd.（Switzerland）
Bayer AG（Germany）
Ascensia Diabetes Care Holdings AG（Switzerland）
Tandem Diabetes Care, Inc.（United States）
LifeScan, Inc.（United States）
AgaMatrix, Inc.（United States）
Glooko, Inc.（United States）
DarioHealth Corp.（Israel）
One Drop（United States）
Ypsomed Holding AG（Switzerland）
ARKRAY, Inc.（Japan）
ACON Laboratories, Inc.（United States）
Becton, Dickinson and Company（United States）
Care Innovations, LLC（United States）
Health2Sync, Inc.（Taiwan）
Emperra GmbH E-Health Technologies（Germany）

結論與建議

簡介目錄

Product Code: SQMIG35A2780

Global Smart Diabetes Management Market size was valued at USD 6.93 Billion in 2024 and is poised to grow from USD 7.95 Billion in 2025 to USD 23.81 Billion by 2033, growing at a CAGR of 14.7% during the forecast period (2026-2033).

The global smart diabetes management market is experiencing significant expansion driven by advancements in healthcare technology and an increasing emphasis on personalized solutions. Key growth factors include heightened awareness around diabetes care, a rising global diabetic population, and the demand for innovative devices that streamline monitoring and treatment processes. Manufacturers and healthcare providers are actively creating smart devices, wearables, and mobile applications to enhance life quality for diabetes patients, ultimately improving disease management and minimizing complications. The integration of artificial intelligence and data analytics into these solutions presents promising opportunities for more tailored diabetes care. As health and wellness continue to be prioritized globally, the market is poised for sustained growth, providing cutting-edge solutions for an expanding demographic of diabetes sufferers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Diabetes Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Diabetes Management Market Segments Analysis

Global Smart Diabetes Management Market is segmented by Device Type, Application, End User and region. Based on Device Type, the market is segmented into Handheld and Wearable. Based on Application, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes and Other. Based on End User, the market is segmented into Hospitals, Home Care Settings, Specialty Clinics and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Smart Diabetes Management Market

One of the key market drivers for the global smart diabetes management market is the increasing prevalence of diabetes worldwide, compounded by rising obesity rates and sedentary lifestyles. As diabetes becomes more commonplace, the demand for innovative management solutions also grows. Smart diabetes management technologies, including wearable devices, mobile applications, and continuous glucose monitoring systems, empower patients with real-time data and insight into their health. This shift toward personalized and proactive health management is not only enhancing patient engagement but also improving overall treatment outcomes, further fueling market expansion and attracting investments in new technologies and solutions tailored for diabetes care.

Restraints in the Global Smart Diabetes Management Market

One of the key market restraints for the global smart diabetes management market is the high cost associated with advanced monitoring devices and digital healthcare solutions. Many patients with diabetes may find it challenging to afford these innovative technologies, particularly in low- to middle-income regions where healthcare budgets are constrained. Additionally, the lack of reimbursement policies for smart diabetes management tools discourages widespread adoption among healthcare professionals and patients. Furthermore, varying levels of technological literacy among patients can hinder the effective utilization of these devices, creating further barriers to market growth and limiting the accessibility of smart diabetes management solutions.

Market Trends of the Global Smart Diabetes Management Market

The Global Smart Diabetes Management market is witnessing robust growth, primarily driven by the rising prevalence of diabetes worldwide. With an aging population and increasingly sedentary lifestyles, the incidence of diabetes continues to escalate, fostering a larger patient base that necessitates advanced management solutions. This shift in demographics is propelling the demand for innovative technologies that improve diabetes monitoring, personalized care, and real-time data analytics. As healthcare systems prioritize effective management strategies, investments in smart devices, mobile applications, and telehealth services are surging, creating a dynamic landscape for comprehensive diabetes management solutions that cater to the evolving needs of patients and healthcare providers alike.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Technology Advancement
Regulatory Landscape
Startup Analysis
Patent Analysis

Global Smart Diabetes Management Market Size by Device Type & CAGR (2026-2033)

Market Overview
Continuous Glucose Monitoring Systems
Smart Insulin Pens
Smart Insulin Pumps
Smart Glucose Meters
Other

Global Smart Diabetes Management Market Size by Device Type & CAGR (2026-2033)

Market Overview
Handheld
Wearable

Global Smart Diabetes Management Market Size by Application & CAGR (2026-2033)

Market Overview
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Other

Global Smart Diabetes Management Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Home Care Settings
Specialty Clinics
Other

Global Smart Diabetes Management Market Size & CAGR (2026-2033)

North America (Device Type, Device Type, Application, End User)
- US
- Canada
Europe (Device Type, Device Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Device Type, Device Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Device Type, Device Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Device Type, Device Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dexcom, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Insulet Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ascensia Diabetes Care Holdings AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tandem Diabetes Care, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LifeScan, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AgaMatrix, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glooko, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DarioHealth Corp. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
One Drop (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ARKRAY, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACON Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Care Innovations, LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Health2Sync, Inc. (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emperra GmbH E-Health Technologies (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments